| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2008, p. 810-813, Vol. 46, No. 2
0095-1137/08/$08.00+0 doi:10.1128/JCM.01004-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
| CASE REPORT |

Division of Clinical Research, National Health Research Institutes, Tainan, Taiwan,1 Departments of Emergency Medicine,2 Pediatrics,3 Surgery, National Cheng Kung University and Hospital, Tainan, Taiwan4
Received 14 May 2007/ Returned for modification 10 October 2007/ Accepted 4 December 2007
Infective endocarditis (IE) caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility (SARV) has been reported worldwide. We report the successful treatment of a pediatric patient with SARV IE and characterization of the infecting strain. The MIC of vancomycin rose from 1.5 to 2 µg/ml, and the SARV was confirmed by population analysis.
Published ahead of print on 12 December 2007.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|